Ardelyx (ARDX) Stock: Buy, Sell, or Hold?
$3.01
+0.08 (+2.73%)
▲
5d:
-0.66%
30d:
-6.81%
90d:
-24.18%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 03, 2026
0d
Protect ARDX Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
HOLD
MODERATE Confidence (81%)
Quality Score
57/100
Position
SLIGHTLY LOW
30-Day Fair Range
$3.01 – $3.27
Position: SLIGHTLY LOW
Forward P/E & Valuation
19.1x
FAIR
vs 16.9x historical avg
Wall Street Target
$12.80
+325.2% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$2.80 / $3.41
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 HOLD: ARDX is fairly valued with market pricing in 4.1% annual growth. Fine to hold or accumulate slowly on dips.
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Oct 28, 2026 at $3.00 · last confirmed Nov 10, 2026
Strength: 7.5/10
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $3.01, which is considered slightly low relative to its 30-day fair value range of $3.01 to $3.27. From a valuation perspective, the stock is trading at a premium (Forward PE: 19.1) compared to its historical average (16.9). At these levels, the market is pricing in 4.1% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, ARDX is in a strong downtrend. Immediate support is located at $2.80, while resistance sits at $3.41.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.80 (+325.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ARDX is in a strong downtrend. Immediate support is located at $2.80, while resistance sits at $3.41.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $12.80 (+325.2%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$3.01 -
$3.27
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
80.5%
Trading Range & Key Levels
30-Day Trading Range
$3.01 -
$3.27
Current vs Trading Range
SLIGHTLY LOW
Support Level
$2.80
Resistance Level
$3.41
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding ARDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 325.2% below Wall St target ($12.80)
- NEUTRAL: Market pricing in 4.1% annual earnings growth - fairly valued
- NEUTRAL: Bottoming setup forming (53/100) — watch for confirmation
Fundamental Context
Forward P/E (Next Year Est.)
19.05
Wall Street Target
$12.80
(+325.2%)
Revenue Growth (YoY)
15.7%
Profit Margin
-11.8%
Valuation Premium vs History
+4.1% premium
PE vs Historical
19.1 vs 16.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+4.1%
(market-implied from PE analysis)
1-Year Target
$3.13
(+4%)
2-Year Target
$3.26
(+8%)
3-Year Target
$3.40
(+13%)
3-Yr Target (if PE normalizes)
(PE: 19→17)
PE COMPRESSION
$3.01
(+0%)
Earnings growth offset by PE compression
Share ARDX Analysis
Share this live ARDX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ARDX)
Bullish
5 Retail Mentions
Reddit / WSB Comments
2
Bearish
StockTwits Volume
3 msgs
24h retail stream
Last Tracked
Nov 10, 2026
Daily AI digest
AI Retail Discussion Summary:
Ardelyx announced its participation in the Jefferies Global Healthcare Conference in London on November 17, 2026.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:28 AM ET
Data refreshes hourly during market hours. Next update: 10:28 AM
Data refreshes hourly during market hours. Next update: 10:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 42 HOLD |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
18 analysts |
$72 | 31 SELL |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ARDX Research Pages
